Core Viewpoint - The company, Jieya Co., announced the approval of a proposal to grant restricted stock to incentive targets during the fourth meeting of its sixth board of directors [2] Group 1 - The board meeting was held on the evening of September 2 [2] - The proposal aims to incentivize specific targets within the company through the issuance of restricted stock [2]

Core Viewpoint - The legal opinion letter from Anhui Tianhe Law Firm confirms that Tongling Jieya Biotechnology Co., Ltd. has complied with relevant laws and regulations regarding its 2025 Restricted Stock Incentive Plan, including necessary approvals and authorizations for the initial grant of restricted stock [1][3][4]. Summary by Sections Approval and Authorization of Grant - The Compensation and Assessment Committee and the Board of Directors have approved the draft of the 2025 Restricted Stock Incentive Plan and related proposals [3][4]. - The company has fulfilled necessary approval and authorization procedures for the grant of restricted stock [4][5]. Basic Information of the Grant - The initial grant date for the restricted stock is set for September 2, 2025, with a total of 1,498,000 shares to be granted to 10 incentive recipients [4][5]. - The grant date complies with the regulations, being within 60 days of the shareholders' meeting approval [5]. Recipients of the Grant - The distribution of the granted shares among the recipients is as follows: - Directors and senior management will receive 38.46% of the total shares, while other incentivized personnel will receive 43.85% [6]. - The total number of shares granted to the 10 recipients is 1,498,000, with a reserved portion of 322,000 shares [6]. Conditions for Granting - Recipients must meet specific conditions to be eligible for the restricted stock, including no negative audit opinions in the last fiscal year and no legal restrictions on participating in stock incentives [7][8]. - The company has confirmed that all conditions for granting the restricted stock have been met [8]. Conclusion - The legal opinion concludes that all necessary approvals, grant dates, recipient qualifications, and conditions have been satisfied, ensuring compliance with the relevant regulations [8].

Core Viewpoint - The company has approved the first grant of restricted stock under its 2025 Restricted Stock Incentive Plan, granting 1,498,000 shares at a price of 12.63 yuan per share to 10 eligible recipients, with the grant date set for September 2, 2025 [1][10][14]. Summary by Sections Incentive Plan Overview - The 2025 Restricted Stock Incentive Plan aims to motivate directors, senior management, and other key personnel deemed necessary for incentivization [1][4]. - The total number of shares granted is 1,498,000, which represents 82.31% of the total incentive plan [3][11]. Grant Details - The grant includes 1,498,000 shares to 10 recipients, with 700,000 shares allocated to directors and senior management, and 798,000 shares to other incentivized personnel [3][11]. - A reserve of 322,000 shares (17.69% of the total) is set aside for future grants [3][11]. Vesting Conditions - The vesting of the restricted stock is contingent upon meeting specific performance targets over three years, with annual assessments [6][7]. - The performance targets are set as follows: - 2025: Revenue growth of at least 25% compared to 2024 - 2026: Revenue growth of at least 50% compared to 2024 - 2027: Revenue growth of at least 100% compared to 2024 [6][7]. Approval Process - The plan has undergone necessary approvals, including reviews by the Compensation and Assessment Committee and the Board of Directors [9][10]. - The company has confirmed that all grant conditions have been met, ensuring compliance with relevant regulations [10][14]. Financial Impact - The fair value of the restricted stock will be calculated using the Black-Scholes model, and the associated costs will be recognized over the vesting period [11][12]. - The estimated total expense for the first grant will impact the company's net profit across the years 2025 to 2028 [12]. Compliance and Legal Review - A legal opinion confirms that the grant complies with all applicable laws and regulations, and the eligibility of the recipients has been verified [14][15].

Group 1 - The incentive plan involves the allocation of restricted stocks among various incentive recipients, with a total of 182,000 shares granted, representing 1.62% of the company's total share capital [1] - The distribution of granted rights includes 70,000 shares (38.46%) for directors and senior management, and 79,800 shares (43.85%) for other personnel deemed necessary for motivation [1] - A reserved portion of 32,200 shares (17.69%) is also included in the incentive plan, bringing the total granted rights to 182,000 shares [1] Group 2 - The company will disclose relevant information about the incentive recipients in a timely and accurate manner after receiving clear opinions from the Compensation and Assessment Committee and legal counsel [2] - The list of other personnel deemed necessary for motivation by the board of directors is also mentioned, indicating a structured approach to employee incentives [2]

Core Viewpoint - The company, Jieya Co., Ltd. (301108.SZ), has announced the successful achievement of the initial grant conditions for its 2025 Restricted Stock Incentive Plan, allowing for the issuance of restricted stock to eligible participants [1] Group 1 - The initial grant date for the restricted stock is set for September 2, 2025 [1] - The price for the restricted stock is determined at 12.63 yuan per share [1] - A total of 1.498 million shares of the second category of restricted stock will be granted to 10 eligible incentive participants [1]

Group 1 - The board of directors of Tongling Jieya Biotechnology Co., Ltd. held its fourth meeting of the sixth session on September 2, 2025, via communication, with all members ensuring the accuracy and completeness of the disclosed information [1] - The board approved the first grant of the 2025 restricted stock incentive plan, agreeing to grant 1,498,000 shares at a price of 12.63 yuan per share to 10 eligible incentive objects, with the grant date set for September 2, 2025 [2] - The voting results for the resolution were 4 votes in favor, 0 against, and 0 abstentions, with certain directors recusing themselves from the vote due to conflicts of interest [2]

Group 1 - The company has reviewed the list of incentive recipients for the 2025 restricted stock incentive plan and confirmed that all recipients meet the necessary legal and regulatory conditions [1][2] - The incentive recipients do not include independent directors, foreign employees, or shareholders holding 5% or more of the company's shares [2] - The first grant date for the incentive plan is set for September 2, 2025, with a total of 10 recipients receiving restricted stock [2]

Group 1 - The company, Jieya Co., Ltd. (SZ 301108), announced on September 2 that its sixth fourth board meeting was held via communication, where it reviewed the proposal for the first grant of restricted stock to incentive objects [1] - For the year 2024, Jieya Co., Ltd.'s revenue composition is as follows: 98.53% from the manufacturing of other daily chemical products and 1.47% from other businesses [1] - As of the report date, Jieya Co., Ltd. has a market capitalization of 3.5 billion yuan [1]

Core Points - The company, Jieya Co., Ltd. (301108.SZ), has announced the grant of 1,498,000 shares of the second category of restricted stock to 10 incentive recipients as part of its 2025 Restricted Stock Incentive Plan [1] - The initial grant date is set for September 2, 2025, with a price of 12.63 yuan per share [1] Summary by Category Company Actions - Jieya Co., Ltd. has fulfilled the conditions for the initial grant of restricted stock as outlined in its incentive plan [1] - The company will grant a total of 1,498,000 shares to 10 eligible incentive recipients [1] Financial Details - The grant price for the restricted stock is set at 12.63 yuan per share [1]

本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示： 铜陵洁雅生物科技股份有限公司（以下简称"公司"或"洁雅股份"）《2025 年限制性股票激励计划（草案）》（以下简称"本激励计划"）规定的限制性股 票首次授予条件已成就，根据 2025 年第四次临时股东会的授权，公司于 2025 年 9 月 2 日召开第六届董事会第四次会议，审议通过了《关于向激励对象首次授 予限制性股票的议案》，同意以 2025 年 9 月 2 日为首次授予日，以 12.63 元/股 的价格向符合条件的 10 名激励对象授予 149.80 万股第二类限制性股票。现将有 关事项说明如下： 证券代码：301108 证券简称：洁雅股份 公告编号：2025-074 铜陵洁雅生物科技股份有限公司 关于向激励对象首次授予限制性股票的公告 一、本激励计划简述及已履行的审批程序 （一）本激励计划简述 1、限制性股票首次授予日：2025 年 9 月 2 日 2、限制性股票首次授予数量：149.80 万股 3、限制性股票首次授予价格：12.63 元/股 4、限制性股票首次授予人数：10 人 5、股权激 ...